Delphi Genetics Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 29
Employees
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $3.86M
Latest Deal Amount
  • Investors
  • 5

Delphi Genetics General Information

Description

Developer of molecular tools designed to offer deoxyribonucleic acid engineering services. The company's tool Staby, is used for synthetic biology, allowing successful cloning of genes and expression of recombinant proteins at a higher yield, enabling researchers to significantly increase the stability of plasmid DNA in host strains, resulting in overall production yield and reproducibility improvement.

Contact Information

Website
www.delphigenetics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Rue A. de Saint-Exupéry, 5
  • 6041 Charleroi
  • Belgium
+32 071 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Delphi Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - General 28-Jun-2016 $3.86M 00.000 Completed Generating Revenue
1. Later Stage VC 10-Mar-2015 00.000 00.000 Completed Generating Revenue
To view Delphi Genetics’s complete valuation and funding history, request access »

Delphi Genetics Executive Team (7)

Name Title Board Seat Contact Info
François Blondel Chief Executive Officer, Managing Director & Chairman
Jean Schaus Chief Business Officer
Sophie Scohy Services Director
Cedric Szpirer Ph.D Founder, Executive & Scientific Director
Thierry Van Reeth Ph.D Manager, Scientific and Sales
You’re viewing 5 of 7 executive team members. Get the full list »

Delphi Genetics Board Members (1)

Name Representing Role Since
François Blondel Delphi Genetics Chief Executive Officer, Managing Director & Chairman 000 0000
To view Delphi Genetics’s complete board members history, request access »

Delphi Genetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delphi Genetics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Invest4 DelphiG2 Other Minority 000 0000 000000 0
Michel Milinkovitch Angel (individual) Minority 000 0000 000000 0
SambrInvest Venture Capital Minority 000 0000 000000 0
Université Libre de Bruxelles University Minority 000 0000 000000 0
Theodorus Venture Capital Minority 000 0000 000000 0
To view Delphi Genetics’s complete investors history, request access »

Ready to get started?

Request a free trial